Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Robin

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Human Reproduction (Oxford, England)|March 7, 2024
Risk factors for poor oocyte yield and oocyte immaturity after GnRH agonist triggeringS Gambini, C Sonigo, G Robin, et al.
Infection|June 23, 1999
Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers, and anti-hepatitis C antibodies among immigrants from the former USSR who arrived in Israel during 1990-1991R Almog, M Low, D Cohen, et al.
Infection and Immunity|October 1, 1996
Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteersD Cohen, S Ashkenazi, M Green, et al.
Stem Cells (Dayton, Ohio)|November 21, 2012
Late outgrowth endothelial cells resemble mature endothelial cells and are not derived from bone marrowOlga Tura, Elizabeth M Skinner, G Robin Barclay, et al.
The Journal of Pathology|February 23, 2011
Human embryonic stem cells rapidly take up and then clear exogenous human and animal prions in vitroZuzana Krejciova, Steve Pells, Enrico Cancellotti, et al.
The Journal of Pediatrics|February 6, 2018
Prevalence of Pediatric Functional Gastrointestinal Disorders Utilizing the Rome IV CriteriaSamantha G Robin, Catherine Keller, Russell Zwiener, et al.
Infection and Immunity|July 19, 2000
Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic escherichia coli-cholera toxin B subunit vaccine in Israeli young adultsD Cohen, N Orr, M Haim, et al.
Infection and Immunity|June 22, 1999
Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602T S Coster, C W Hoge, L L VanDeVerg, et al.
Basic and Clinical Andrology|July 21, 2020
COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d'Andrologie de langue Française SALF)S Hamdi, M Bendayan, E Huyghe, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Clinical trials of Shigella vaccines in IsraelD Cohen, S Ashkenazi, M Green, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Human Reproduction (Oxford, England)|March 7, 2024
Risk factors for poor oocyte yield and oocyte immaturity after GnRH agonist triggeringS Gambini, C Sonigo, G Robin, et al.
Infection|June 23, 1999
Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers, and anti-hepatitis C antibodies among immigrants from the former USSR who arrived in Israel during 1990-1991R Almog, M Low, D Cohen, et al.
Infection and Immunity|October 1, 1996
Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteersD Cohen, S Ashkenazi, M Green, et al.
Stem Cells (Dayton, Ohio)|November 21, 2012
Late outgrowth endothelial cells resemble mature endothelial cells and are not derived from bone marrowOlga Tura, Elizabeth M Skinner, G Robin Barclay, et al.
The Journal of Pathology|February 23, 2011
Human embryonic stem cells rapidly take up and then clear exogenous human and animal prions in vitroZuzana Krejciova, Steve Pells, Enrico Cancellotti, et al.
The Journal of Pediatrics|February 6, 2018
Prevalence of Pediatric Functional Gastrointestinal Disorders Utilizing the Rome IV CriteriaSamantha G Robin, Catherine Keller, Russell Zwiener, et al.
Infection and Immunity|July 19, 2000
Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic escherichia coli-cholera toxin B subunit vaccine in Israeli young adultsD Cohen, N Orr, M Haim, et al.
Infection and Immunity|June 22, 1999
Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602T S Coster, C W Hoge, L L VanDeVerg, et al.
Basic and Clinical Andrology|July 21, 2020
COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d'Andrologie de langue Française SALF)S Hamdi, M Bendayan, E Huyghe, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Clinical trials of Shigella vaccines in IsraelD Cohen, S Ashkenazi, M Green, et al.
Pageof 16